Inspire Medical Systems, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference
Rhea-AI Summary
Inspire Medical Systems (NYSE: INSP) announced its management team will present at the Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2, 2025 at 11:30 a.m. Eastern Time.
The presentation will be available via a live webcast and a replay will be hosted for two weeks in the Event Archive on Inspire’s investor website at https://investors.inspiresleep.com.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, INSP declined 1.53%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
MINNEAPOLIS, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2, 2025.
Inspire is scheduled to present at 11:30 a.m. Eastern Time. The presentation will be accessible via a live webcast here.
A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443